Valeo Financial Advisors LLC acquired a new stake in UnitedHealth Group Inc (NYSE:UNH) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,313 shares of the healthcare conglomerate’s stock, valued at approximately $453,000.

Several other institutional investors have also recently made changes to their positions in UNH. Beach Investment Management LLC. acquired a new stake in shares of UnitedHealth Group in the second quarter valued at $556,000. New Jersey Better Educational Savings Trust acquired a new stake in shares of UnitedHealth Group in the second quarter valued at $556,000. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its holdings in shares of UnitedHealth Group by 1.1% in the second quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 301,700 shares of the healthcare conglomerate’s stock valued at $55,941,000 after buying an additional 3,362 shares during the period. First Trust Advisors LP lifted its holdings in shares of UnitedHealth Group by 7.5% in the second quarter. First Trust Advisors LP now owns 327,481 shares of the healthcare conglomerate’s stock valued at $60,722,000 after buying an additional 22,800 shares during the period. Finally, DekaBank Deutsche Girozentrale lifted its holdings in shares of UnitedHealth Group by 5.1% in the second quarter. DekaBank Deutsche Girozentrale now owns 479,837 shares of the healthcare conglomerate’s stock valued at $89,532,000 after buying an additional 23,342 shares during the period. Institutional investors and hedge funds own 86.24% of the company’s stock.

UnitedHealth Group Inc (NYSE UNH) opened at $225.82 on Thursday. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58. UnitedHealth Group Inc has a 52-week low of $156.49 and a 52-week high of $250.79. The firm has a market capitalization of $218,830.00, a price-to-earnings ratio of 21.08, a P/E/G ratio of 1.28 and a beta of 0.70.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. During the same period in the prior year, the firm posted $2.11 EPS. The business’s revenue was up 9.5% compared to the same quarter last year. equities analysts predict that UnitedHealth Group Inc will post 12.51 EPS for the current fiscal year.

In other UnitedHealth Group news, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Kenneth Irwin Shine sold 457 shares of the company’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 53,853 shares of company stock worth $12,358,508. Insiders own 0.89% of the company’s stock.

A number of equities research analysts have recently issued reports on the company. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price on the stock in a research report on Saturday, January 20th. Argus boosted their target price on UnitedHealth Group to $270.00 and gave the stock a “buy” rating in a research report on Thursday, January 18th. Credit Suisse Group boosted their target price on UnitedHealth Group from $252.00 to $260.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 17th. Oppenheimer boosted their target price on UnitedHealth Group from $260.00 to $240.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 17th. Finally, Cantor Fitzgerald boosted their target price on UnitedHealth Group to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 17th. Two analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $243.22.

ILLEGAL ACTIVITY NOTICE: This report was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://www.dailypolitical.com/2018/02/08/valeo-financial-advisors-llc-invests-453000-in-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.